Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/1999
02/16/1999US5871982 Hybrid vectors and genes
02/16/1999US5871977 DNA encoding enzyme recombinant DNA and enzyme transformant, and their preparation and uses
02/16/1999US5871976 Genetic engineering
02/16/1999US5871975 Method for suppressing inhibition of enzyme-mediated nucleic acid amplification reactions by ionic detergents
02/16/1999US5871974 Recombinant expression of heteromeric receptors on the surface of filamentous bacteriophage
02/16/1999US5871973 Cell division regulators
02/16/1999US5871970 Calcium-binding protein
02/16/1999US5871969 Treating spinal cord injuries and malaria; antitumor and wound healing agents; diagnosing cancer; genetic engineering
02/16/1999US5871968 P21WAF1 derivatives and diagnostic methods
02/16/1999US5871967 Cloning of a novel G-Protein coupled 7TM receptor
02/16/1999US5871966 Genetic engineering; degrading plant cell walls
02/16/1999US5871964 Human C-type lectin
02/16/1999US5871962 Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods
02/16/1999US5871961 Nucleic acids encoding CR2 polypeptides, vector and transformed cell thereof, and expression thereof
02/16/1999US5871960 Nucleic acids encoding CR5 polypeptide, vector and transformed cell thereof, and expression thereof
02/16/1999US5871958 Mutant rev genes encoding transdominant repressors of HIV replication
02/16/1999US5871957 Stable DNA constructs
02/16/1999US5871956 Recombinant methods for production of serine inhibitors and DNA sequences useful for same
02/16/1999US5871950 Methods of treating autoimmune diseases and transplantation rejection
02/16/1999US5871945 Modulators of anchoring protein function
02/16/1999US5871943 Immunoassay comprising a truncated pneumococcal surface protein A (PspA)
02/16/1999US5871940 Assays for modulators of drosophila cation channel function
02/16/1999US5871934 Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins
02/16/1999US5871933 Diagnosing, screening, and confirming infection with accuracy; vaccines
02/16/1999US5871931 Methods for detecting mammalian tub protein and RNA
02/16/1999US5871930 High affinity immunoglobulin E receptor-like protein
02/16/1999US5871927 Nucleotide analog-containing hybrid subtraction with sequentially enzymatic digestion
02/16/1999US5871925 Determining whether two microsatellite markers are rearranged in tumor tissue; testing for familial colon cancer gene in humans; diagnosis, prognosis, prevention
02/16/1999US5871923 Methods for screening for antimycotics
02/16/1999US5871922 Genes involved in the biosynthetic pathway of carbapenem
02/16/1999US5871921 Hybridization, covalent bonding, exposing to exonuclease; detecting; genetic engineering
02/16/1999US5871919 Method of identifying agents that affect human NHE3
02/16/1999US5871916 Cancer diagnosis by analyzing gene expression of ecdn paucimolecular protein; receptor binding assays
02/16/1999US5871913 Forms a complex with a human immunodeficiency virus envelope glycoprotein
02/16/1999US5871911 Annealing target and pilot nucleic acids to form duplex; exposing to polymerase; genetic engineering
02/16/1999US5871909 Human cellular retinoic acid binding protein I and II DNA and methods of use
02/16/1999US5871907 Methods for producing members of specific binding pairs
02/16/1999US5871903 HCV isolates
02/16/1999US5871902 Detecting and localizing specific nucleic acid sequences in a sample with a high degree of sensitivity and specificity
02/16/1999US5871901 Assay for inhibitors of DP-1 and other DP proteins
02/16/1999US5871753 A compound comprising two or more multimerized ligands each independently selected from the group consisting of fk506, fk520 and cyclosporin, or macrocyclic derivatives thereof.
02/16/1999US5871745 Isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg
02/16/1999US5871744 Method for generating birnavirus from synthetic RNA transcripts
02/16/1999US5871742 Dna codes for polypeptides with amino acid sequences
02/16/1999US5871740 Genetic engineering with proteins, antiinflammatory agents and gene expression
02/16/1999US5871738 Nematode vaccine
02/16/1999US5871735 Isoferritin as a marker for pathological pregnancy
02/16/1999US5871732 Dna sequences and genetic engineering for aids
02/16/1999US5871729 Superoxide dismutase-4
02/16/1999US5871727 Targeted adenovirus vectors
02/16/1999US5871726 Tissue specific and tumor growth supperssion by adenovirus comprising prostate specific antigen
02/16/1999US5871697 Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
02/16/1999US5871464 Administration of gene therapy to target cells and tissues
02/16/1999CA2142297C Liquid detergents containing a peptide aldehyde
02/16/1999CA2122112C Adrenomedullin
02/16/1999CA2002796C Production of fermented food products
02/16/1999CA2000913C Family of high affinity antibodies for cancer treatment
02/16/1999CA1340398C Bovine placental lactogen gene
02/16/1999CA1340397C Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception
02/16/1999CA1340393C Production of recombinant human psti in saccharomyces cerevisiae
02/16/1999CA1340391C Monoclonal antibodies against atrial, natriuretic peptides of humans
02/15/1999CA2224096A1 The g-protein coupled receptor hfia041
02/14/1999CA2239264A1 Novel uses
02/13/1999CA2240637A1 Novel ratb
02/13/1999CA2240627A1 Novel ratc
02/13/1999CA2240623A1 Novel rata
02/13/1999CA2240607A1 Novel vascular smooth muscle cell growth factor
02/13/1999CA2234415A1 A method of identifying agonist and antagonists for tumor necrosis related receptors tr1 and tr2
02/12/1999CA2239837A1 Novel murd
02/12/1999CA2239835A1 Human sdr2 cdna clone
02/12/1999CA2239819A1 Ftsz
02/12/1999CA2231728A1 Mray
02/11/1999WO1999006840A1 Collagen-peptide assay method
02/11/1999WO1999006833A1 Methods for obtaining probes of peptide function
02/11/1999WO1999006599A1 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus
02/11/1999WO1999006597A1 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
02/11/1999WO1999006595A1 Dendritic nucleic acids exhibiting maximal self-assembly
02/11/1999WO1999006593A1 Solid support with attached molecules
02/11/1999WO1999006587A2 Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
02/11/1999WO1999006583A1 Targeted hsv vectors
02/11/1999WO1999006582A1 Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences
02/11/1999WO1999006581A1 Transgenic plants using the tdc gene for crop improvement
02/11/1999WO1999006580A2 Stress tolerance and delayed senescence in plants
02/11/1999WO1999006579A2 Inhibition of unwanted hormone action in plants
02/11/1999WO1999006578A2 Genetic method for controlling sprouting
02/11/1999WO1999006577A2 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide
02/11/1999WO1999006576A1 A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
02/11/1999WO1999006575A1 Starch debranching enzymes
02/11/1999WO1999006574A1 Cellulose degrading enzymes of aspergillus
02/11/1999WO1999006573A1 New beta-glucanase from a bacillus
02/11/1999WO1999006572A1 Synaptojanin isoform
02/11/1999WO1999006571A1 Cytokinin oxidase
02/11/1999WO1999006570A2 Plasmids
02/11/1999WO1999006569A1 Cytotoxic polypeptide (fragment) derived from ribonuclease
02/11/1999WO1999006568A1 Bacillus thuringiensis cry6-toxins with improved activity
02/11/1999WO1999006567A1 Secretion of carrier-bonded proteins into the periplasma and the extracellular space
02/11/1999WO1999006566A1 Production of transgenic poinsettia
02/11/1999WO1999006565A2 Antifreeze proteins, dna and expression systems
02/11/1999WO1999006564A1 Expression of antimicrobial peptide genes in plants, and their use in creating resistance to multiple plant pathogens
02/11/1999WO1999006563A1 Novel bone mineralization proteins, dna, vectors, expression systems